Building Flexibility into the Future of Next Generation Therapies: Expanded CTM Manufacturing and Integrated Analytical Resources

As the demand for innovative and nasal drug products continues to grow, flexibility, collaboration, and technical excellence have become critical enablers of successful  development. With the expansion of our pharmaceutical services and clinical trial manufacturing capabilities in Cambridge, we are strengthening our ability to support next-generation therapies from early development through to the clinic.

This expert interview with Teresa Iley, our Director Pharmaceutical Development & Manufacturing, explores how greater flexibility can be integrated into the development of inhaled and nasal drug products to address increasing complexity in formulation, device design, and regulatory expectations. It highlights the importance of adopting adaptable development strategies that can accommodate evolving requirements across chemistry, manufacturing, and controls (CMC), while maintaining product quality and performance.

Read the full expert interview >